An overview of randomized trials was conducted to evaluate the effects of intravenous streptokinase in patients with acute myocardial infarction.
Meta-Analysis
Intracoronary infusion of streptokinase in patients with acute myocardial infarction is an exciting and innovative technique for reperfusion of the ischemic myocardium,1 2 3 4 but its net benefits have not yet been reliably estimated.Intravenous infusion of streptokinase is less invasive, less expensive, and easier than intracoronary infusion, and its effects have already been studied in randomized trials. Inevitably, when several trials address the same or a similar question, they are unlikely to yield identical results, and in these circumstances an overview of the results of all the strictly randomized trials can be useful.5 6 7 Although the play of chance may well produce . . .
Stampfer et al. (Thu,) conducted a meta-analysis in Acute Myocardial Infarction. Intravenous Streptokinase was evaluated. An overview of randomized trials was conducted to evaluate the effects of intravenous streptokinase in patients with acute myocardial infarction.